{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:54:36Z","timestamp":1782284076171,"version":"3.54.5"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T00:00:00Z","timestamp":1202860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Common polymorphisms in genes encoding for cytokines implicated in the inflammatory response and Th1\/Th2 balance might play a role in the development and prognosis of chronic lymphocytic leukaemia (CLL). To test the hypothesis, we investigated 13 single nucleotide polymorphisms (SNPs) in nine of such genes in a population\u2010based case\u2010control study, conducted in the Italian region of Sardinia in 1999\u20132003. Forty incident CLL cases and 113 population controls were available for study. The following SNPs were selected: <jats:italic>IL1A\u2010889<\/jats:italic>C<jats:italic>\u2009&gt;\u2009T, IL1RN 9589<\/jats:italic>A<jats:italic>\u2009&gt;\u2009<\/jats:italic>T<jats:italic>, IL1B\u201031<\/jats:italic>C<jats:italic>\u2009&gt;\u2009<\/jats:italic>T<jats:italic>, IL1B\u2010511<\/jats:italic>C<jats:italic>\u2009&gt;\u2009<\/jats:italic>T<jats:italic>, IL2\u2010384<\/jats:italic>T<jats:italic>\u2009&gt;\u2009<\/jats:italic>G<jats:italic>, IL6\u2010174<\/jats:italic>G<jats:italic>\u2009&gt;\u2009<\/jats:italic>C<jats:italic>, IL6\u2010597<\/jats:italic>G<jats:italic>\u2009&gt;\u2009<\/jats:italic>A<jats:italic>, IL10\u20101082<\/jats:italic>A<jats:italic>\u2009&gt;\u2009<\/jats:italic>G<jats:italic>, IL10\u20103575<\/jats:italic>T<jats:italic>\u2009&gt;\u2009<\/jats:italic>A<jats:italic>, TNF\u2010308<\/jats:italic>G<jats:italic>\u2009&gt;\u2009<\/jats:italic>A<jats:italic>, LTA\u2010 91<\/jats:italic>A<jats:italic>\u2009&gt;\u2009<\/jats:italic>C<jats:italic>, LTA 252<\/jats:italic>A<jats:italic>\u2009&gt;\u2009<\/jats:italic>G and <jats:italic>CARD15 nt1007<\/jats:italic>. After adjusting by age and gender, individuals homozygous for the <jats:italic>IL1B\u2010511<\/jats:italic>T allele run a lower risk of CLL (OR\u2009=\u20090.1, 95% CI 0.0, 0.8, <jats:italic>p<\/jats:italic>\u2009=\u20090.032), while risk showed a 4.5\u2010fold increase associated with the genotype homozygous for the <jats:italic>IL6\u2010174<\/jats:italic>C allele (OR\u2009=\u20094.5; 95% CI 1.1, 19.3, <jats:italic>p<\/jats:italic>\u2009=\u20090.041). Individuals homozygous for the <jats:italic>IL6\u2010174<\/jats:italic>C allele and carrying the homozygous <jats:italic>IL1B\u2010511<\/jats:italic>C allele showed an 11\u2010fold increase in CLL risk (OR\u2009=\u200911.4, 95% CI 1.9, 69.4, <jats:italic>p<\/jats:italic>\u2009=\u20090.008). None of the other interleukin SNPs evaluated showed any association with CLL risk. Large multicentre pooled studies are warranted, achieving the statistical power required to confirm whether IL6 and IL1B gene polymorphisms might play a role in CLL development and prognosis, as well as the null associations herein reported. Copyright \u00a9 2008 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hon.843","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T11:16:24Z","timestamp":1202901384000},"page":"98-103","source":"Crossref","is-referenced-by-count":39,"title":["Interleukin\u20101B (IL1B) and interleukin\u20106 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia"],"prefix":"10.1002","volume":"26","author":[{"given":"Maria G.","family":"Ennas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Cabras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Gabbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Serpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,13]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"2321","volume-title":"Cancer. Principles and Practice of Oncology","author":"Deisseroth AB","year":"1997"},{"key":"e_1_2_1_3_2","volume-title":"Bone Marrow Pathology","author":"Foucar K","year":"1995"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00097-7"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood.V84.7.2297.2297","article-title":"Interleukin\u20105 (IL\u20105) increases spontaneous apoptosis of B\u2010cell chronic lymphocytic leukemia cells in vitro independently of bcl\u20102 expression and is inhibited by IL\u20104","volume":"84","author":"Mainou\u2010Fowler T","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0701553104"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02849990"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.6.3830"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.01.004"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.05.022"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500158789"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21994"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.9912636.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609093434"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.48.5.482"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10772"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.256"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109099331"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05240.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.2005.B0919"},{"key":"e_1_2_1_21_2","first-page":"239","article-title":"Polymorphism within the second intron of the IL\u20101 receptor antagonist gene in patients with hematopoietic malignancies","volume":"2","author":"Demeter J","year":"1996","journal-title":"Cytokines Mol Ther"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600758645"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364337"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70434-4"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-005-4908-x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1744"},{"key":"e_1_2_1_28_2","first-page":"157","article-title":"Interleukin\u20106 and interleukin\u201012 blood levels in patients with chronic B\u2010cell lymphocytic leukemia [in Polish with English abstract]","volume":"16","author":"Parfienczyk A","year":"2004","journal-title":"Pol Merkur Lekarski"},{"key":"e_1_2_1_29_2","first-page":"600","article-title":"Interleukin\u20101 beta, interleukin\u20101 receptor antagonist and interleukin\u20106 plasma levels and cytokine gene polymorphisms in chronic lymphocytic  leukemia: correlation with prognostic parameters","volume":"85","author":"Hulkkonen J","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi184"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-005-0082-3"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2005.02.002"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3803"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2004.03.006"},{"key":"e_1_2_1_35_2","first-page":"445","article-title":"Interleukins, TNF\u2010alpha and beta\u20102M in patients with B cell chronic lymphocytic leukemia","volume":"17","author":"Mavridis AK","year":"1998","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363773"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh349"},{"key":"e_1_2_1_38_2","first-page":"154","article-title":"Analysis of single nucleotide polymorphisms in the promoter region of interleukin\u201010 by denaturing high\u2010performance liquid chromatography","volume":"16","author":"Guzowski D","year":"2005","journal-title":"J Biomol Tech"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.843","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T19:58:38Z","timestamp":1699991918000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,13]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1002\/hon.843"],"URL":"https:\/\/doi.org\/10.1002\/hon.843","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,13]]}}}